| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Recursion Pharmaceuticals, Inc. (RXRX) has 11 insiders with recent SEC Form 4 filings, including 0 buys and 14 sells. RXRX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 6.65M | $21.78M | - | |
| CEO | 2.26M | $7.41M | - | |
| Dir | 1.24M | $4.06M | - | |
| CFO | 1.22M | $4.00M | - | |
| Other | 1.10M | $3.59M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 23, 2025 | Gibson Christopher70 | Chief Executive Officer | Sell | 100,000 | $5.70 | $570,000.00 | -9.5% | -19.5% | - | |
| Oct 10, 2025 | Gibson Christopher70 | Chief Executive Officer | Sell | 100,000 | $6.04 | $604,000.00 | -9.3% | -11.7% | - | |
| Sep 25, 2025 | Gibson Christopher70 | Chief Executive Officer | Sell | 100,000 | $4.76 | $476,000.00 | -9.5% | -5.0% | - | |
| Sep 10, 2025 | Gibson Christopher70 | Chief Executive Officer | Sell | 100,000 | $4.71 | $471,000.00 | -9.3% | +5.1% | - | |
| Aug 26, 2025 | Gibson Christopher70 | Chief Executive Officer | Sell | 100,000 | $4.84 | $484,000.00 | -9.5% | -10.4% | - | |
| Aug 18, 2025 | Khan Najat | Chief R&D Commercial Officer | Sell | 36,599 | $5.52 | $202,172.88 | -5.2% | -25.4% | - | |
| Aug 11, 2025 | Gibson Christopher70 | Chief Executive Officer | Sell | 618,175 | $5.28 | $3,263,964.00 | -38.1% | -14.7% | - | |
| Mar 27, 2025 | Gibson Christopher70 | Chief Executive Officer | Sell | 138,574 | $6.04 | $836,986.96 | -11.0% | -13.6% | -50.8% | |
| Mar 6, 2025 | Gibson Christopher70 | Chief Executive Officer | Sell | 40,000 | $6.48 | $259,000.00 | -1.6% | -21.3% | -44.7% | |
| Feb 6, 2025 | Gibson Christopher70 | Chief Executive Officer | Sell | 40,000 | $7.90 | $316,000.00 | -1.5% | -42.1% | -45.0% |